Unknown

Dataset Information

Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program.


ABSTRACT:

Background

The endometrial cancer molecular classification has been integrated into the 2020 World Health Organization (WHO) diagnostic classification and European treatment guidelines, and provides direction towards more effective and less toxic adjuvant treatment strategies for women with endometrial cancer.

Primary objectives

The RAINBO program of clinical trials will investigate four molecular class-directed adjuvant treatment strategies following surgical resection to either increase cure rates through the addition of novel targeted therapies or safely reduce toxicity and improve quality of life through treatment de-escalation.

Study hypothesis

Molecular-directed adjuvant treatment strategies will improve clinical outcomes and reduce toxicity of unwarranted thera

SUBMITTER: RAINBO Research Consortium 

PROVIDER: S-EPMC9811074 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature